Simulations Plus Inc represents values of innovation, scientific excellence, and customer satisfaction. With a corporate philosophy focused on advancing pharmaceutical research and enhancing drug development, Simulations Plus Inc strives to provide cutting-edge software and consulting services. By combining advanced technologies and domain knowledge, the company facilitates cost-effective and efficient drug discovery and development processes. Simulations Plus Inc is committed to delivering high-quality solutions, fostering collaborative relationships, and continuously improving its products and services.

Simulations Plus Inc is primarily present in the United States.

Simulations Plus Inc has achieved significant milestones throughout its history. Some notable accomplishments include the development and release of their industry-leading software solutions, such as GastroPlus™ and DDDPlus™, which have gained widespread recognition and adoption in the pharmaceutical industry. The company has also formed strategic partnerships and collaborations with top pharmaceutical companies, further establishing its presence and credibility in the market. Additionally, Simulations Plus Inc has a strong track record of achieving consistent revenue growth and delivering value to its shareholders. These achievements reflect the company's commitment to innovation, excellence, and meeting the evolving needs of the life sciences industry.

Simulations Plus Inc is a leading provider of simulation and modeling software for the pharmaceutical and biotechnology industries. Established in 1996, the company has amassed extensive expertise in the field. Simulations Plus Inc has developed a strong reputation for its cutting-edge technology and innovative solutions, helping pharmaceutical companies optimize drug discovery and development processes. With a focus on increasing efficiency and reducing costs, Simulations Plus Inc has become a trusted partner for numerous organizations worldwide. The company's commitment to excellence has earned them recognition and a loyal customer base. Simulations Plus Inc continues to drive advancements in the industry, delivering impactful software solutions that streamline drug development.

The main competitors of Simulations Plus Inc in the market include Certara, Inc and Dassault Systèmes.

Simulations Plus Inc is primarily active in the pharmaceutical and biotechnology industries. With a focus on simulation software and consulting services, the company provides cutting-edge solutions for drug discovery and development. Simulations Plus Inc's expertise in modeling and simulation technologies helps pharmaceutical companies optimize their drug formulation and dosage strategies. By leveraging their industry-leading software platforms, Simulations Plus Inc supports the efficient research and development of new therapies, enhancing the overall success and effectiveness of pharmaceutical companies.

The business model of Simulations Plus Inc revolves around providing software and consulting services for pharmaceutical research and development. As a leading provider in the field of drug discovery and development, Simulations Plus Inc aims to enhance the efficiency and effectiveness of the pharmaceutical industry through their innovative solutions. By utilizing computer modeling and simulation software, the company assists in predicting and optimizing drug properties, interactions, and outcomes. This enables scientists and researchers to make informed decisions throughout the drug development process, leading to improved efficacy, safety, and reduced costs. Simulations Plus Inc's comprehensive solutions cater to the needs of pharmaceutical companies, regulatory agencies, and academia worldwide.

مُعامل القيمة السوقية إلى الأرباح لـ Simulations Plus هو ٥٧٫٧٠.

مُعامِل القيمة إلى المبيعات Simulations Plus هو ٨٫٢٠.

نقاط جودة AlleAktien لـ Simulations Plus هي 5/10.

Simulations Plus الإيرادات هي ٧٠٫٠١ مليون. USD.

صافي الربح Simulations Plus هو ٩٫٩٥ مليون. USD.

Simulations Plus Inc. is a leading company in the field of simulation technology and software development. It provides solutions for researchers and experts in various industries, including biotechnology, pharmaceuticals, agriculture, food technology, and more. The company offers a range of products and tools for data analysis and innovative strategy development to bring new products and applications to the market. Some of its notable products include PK-SIM, MoBi, ADMET Predictor, GastroPlus, DILIsym, and MedChem Studio. Simulations Plus also offers solutions for the agricultural sector, such as Cartagenia, Crop Laptop, and Dose Response Toxicology. The company provides training and support to its customers, aiming to optimize their business processes. Its business model focuses on processing and analyzing large data sets to provide relevant insights and support decision-making processes. Simulations Plus aims to expand into new markets and develop products based on the latest technological advancements.

يوزع Simulations Plus أرباحًا قدرها ٠٫٢٤ USD من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ Simulations Plus في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـSimulations Plus هو US8292141053.

رمز WKN لـ Simulations Plus هو 924294.

الرمز المُختصر لـ Simulations Plus هو SLP.

خلال آخر 12 شهراً، دفعت Simulations Plus توزيعات أرباح بقيمة ٠٫١٨ USD . وهذا يعادل عائد توزيعات أرباح يقارب ٠٫٦٤ %. ومن المتوقع أن تدفع Simulations Plus خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٠٫١٩ USD.

نسبة توزيعات الأرباح الحالية لـ Simulations Plus هي ٠٫٦٤ %.

Simulations Plus يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر نوفمبر, فبراير, مايو, أغسطس.

Simulations Plus دفعت توزيعات الأرباح كل عام خلال الـ0 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٠٫١٩ USD. وهذا يعادل عائد توزيعات أرباح قدره ٠٫٦٦ %.

Simulations Plus يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ٠٫٠٦ USD من Simulations Plus المُعلن عنها في ٥‏/٨‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٢٩‏/٧‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ٥‏/٨‏/٢٠٢٤.

في العام 2023، وزعت Simulations Plus ٠٫٢٤ USD كأرباح أسهم.

يتم توزيع أرباح Simulations Plus بالعملة USD.